Literature DB >> 27888398

The Value of the Electrocardiogram for Evaluating Prognosis in Patients with Idiopathic Pulmonary Arterial Hypertension.

Xiao-Ling Cheng1, Jian-Guo He1, Zhi-Hong Liu1, Qing Gu1, Xin-Hai Ni1, Zhi-Hui Zhao1, Qin Luo1, Chang-Ming Xiong2.   

Abstract

BACKGROUND: Association between electrocardiography (ECG) features and right ventricular anatomy and physiology has been established. This study is aimed to identify the value of 12-lead ECG in evaluating prognosis of patients with idiopathic pulmonary arterial hypertension (IPAH).
METHOD: 194 patients with newly diagnosed IPAH were included in this study. Correlations between electrocardiography variables and hemodynamics were assessed. Univariate and multivariable cox regression analysis were performed to identify ECG variables for predicting all-cause mortality in IPAH.
RESULTS: Partial correlation analysis showed that P wave amplitude in lead II correlated with the mean pulmonary arterial pressure (mPAP, r = 0.349, p ≤ 0.001) and cardiac index (CI, r = -0.224, p = 0.002); R wave amplitude in V1 correlated with mPAP (r = 0.359, p ≤ 0.001); S wave amplitude in V6 correlated with mPAP (r = 0.259, p = 0.030) and CI (r = -0.220, p = 0.003). P wave amplitude in lead II (HR 1.555, p = 0.033) and R wave amplitude in lead aVR (HR 5.058, p < 0.001) were the independent predictors of all-cause mortality. Kaplan-Meier survival curves showed patients with a p ≥ 0.25 mv in lead II, and R ≥ 0.4 mv in lead aVR had lower 3-year survival (55 vs. 91%, p < 0.001).
CONCLUSION: Specific lead-12 ECG features could reflect right ventricular overload hemodynamics, and are useful to evaluate prognosis of patients with IPAH.

Entities:  

Keywords:  Electrocardiography; Prognosis; Pulmonary hypertension

Mesh:

Year:  2016        PMID: 27888398     DOI: 10.1007/s00408-016-9967-z

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  20 in total

1.  Electrocardiogram for the diagnosis of right ventricular hypertrophy and dilation in idiopathic pulmonary arterial hypertension.

Authors:  Grzegorz Kopeć; Anna Tyrka; Tomasz Miszalski-Jamka; Maciej Sobień; Marcin Waligóra; Mateusz Brózda; Piotr Podolec
Journal:  Circ J       Date:  2012-04-13       Impact factor: 2.993

2.  Predictive values of the electrocardiogram in diagnosing pulmonary hypertension.

Authors:  Khalid Al-Naamani; Tarek Hijal; Viviane Nguyen; Steve Andrew; Tam Nguyen; Thao Huynh
Journal:  Int J Cardiol       Date:  2007-07-24       Impact factor: 4.164

Review 3.  AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part V: electrocardiogram changes associated with cardiac chamber hypertrophy: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: endorsed by the International Society for Computerized Electrocardiology.

Authors:  E William Hancock; Barbara J Deal; David M Mirvis; Peter Okin; Paul Kligfield; Leonard S Gettes; James J Bailey; Rory Childers; Anton Gorgels; Mark Josephson; Jan A Kors; Peter Macfarlane; Jay W Mason; Olle Pahlm; Pentti M Rautaharju; Borys Surawicz; Gerard van Herpen; Galen S Wagner; Hein Wellens
Journal:  Circulation       Date:  2009-02-19       Impact factor: 29.690

4.  The electrocardiographic diagnosis of right ventricular hypertrophy.

Authors:  G B MYERS; H A KLEIN; B E STOFER
Journal:  Am Heart J       Date:  1948-01       Impact factor: 4.749

5.  The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension.

Authors:  N Nickel; H Golpon; M Greer; L Knudsen; K Olsson; V Westerkamp; T Welte; M M Hoeper
Journal:  Eur Respir J       Date:  2011-09-01       Impact factor: 16.671

6.  Surface electrocardiogram detects signs of right ventricular pressure overload among acute-decompensated heart failure with preserved ejection fraction patients.

Authors:  Paula Martínez Santos; Isidre Vilacosta; Elena Batlle López; Beatriz Sánchez Sauce; Elena España Barrio; Julia Jiménez Valtierra; Adriana de la Rosa Riestra; Raquel Campuzano Ruiz
Journal:  J Electrocardiol       Date:  2016-02-26       Impact factor: 1.438

7.  [Clinical characteristics of 161 Chinese patients with idiopathic pulmonary arterial hypertension].

Authors:  Wei-bin Jia; Xin Jiang; Xiang-rong Zuo; Jing He; Qin-hua Zhao; Rong Jiang; Zhi-cheng Jing
Journal:  Zhonghua Xin Xue Guan Bing Za Zhi       Date:  2012-08

8.  Portopulmonary hypertension: a report from the US-based REVEAL Registry.

Authors:  Michael J Krowka; Dave P Miller; Robyn J Barst; Darren Taichman; Raed A Dweik; David B Badesch; Michael D McGoon
Journal:  Chest       Date:  2011-07-21       Impact factor: 9.410

9.  Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry.

Authors:  David B Badesch; Gary E Raskob; C Greg Elliott; Abby M Krichman; Harrison W Farber; Adaani E Frost; Robyn J Barst; Raymond L Benza; Theodore G Liou; Michelle Turner; Scott Giles; Kathy Feldkircher; Dave P Miller; Michael D McGoon
Journal:  Chest       Date:  2009-10-16       Impact factor: 9.410

10.  Frequency of supraventricular arrhythmias in patients with idiopathic pulmonary arterial hypertension.

Authors:  Li Wen; Ming-Li Sun; Pei An; Xin Jiang; Kai Sun; Lu Zheng; Qian-Qian Liu; Lan Wang; Qin-Hua Zhao; Jing He; Zhi-Cheng Jing
Journal:  Am J Cardiol       Date:  2014-08-13       Impact factor: 2.778

View more
  6 in total

1.  ECG Markers of Hemodynamic Improvement in Patients with Pulmonary Hypertension.

Authors:  Marcin Waligóra; Anna Tyrka; Piotr Podolec; Grzegorz Kopeć
Journal:  Biomed Res Int       Date:  2018-04-10       Impact factor: 3.411

2.  Utility of the amplitude of RV1+SV5/6 in assessment of pulmonary hypertension.

Authors:  Sachiyo Igata; Nobuhiro Tahara; Yoichi Sugiyama; Munehisa Bekki; Jun Kumanomido; Atsuko Tahara; Akihiro Honda; Shoko Maeda; Kazutaka Nashiki; Tomohisa Nakamura; Jiahui Sun; Toshi Abe; Yoshihiro Fukumoto
Journal:  PLoS One       Date:  2018-11-26       Impact factor: 3.240

3.  Association of Electrocardiographic Signs of Right Ventricular Hypertrophy and Clot Localization in Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Sylwia Sławek-Szmyt; Aleksander Araszkiewicz; Stanisław Jankiewicz; Anna Smukowska-Gorynia; Marek Grygier; Magdalena Janus; Maciej Lesiak; Tatiana Mularek-Kubzdela
Journal:  J Clin Med       Date:  2022-01-26       Impact factor: 4.241

4.  ECG in the clinical and prognostic evaluation of patients with pulmonary arterial hypertension: an underestimated value.

Authors:  Tomasz Adam Michalski; Joanna Pszczola; Anna Lisowska; Malgorzata Knapp; Bozena Sobkowicz; Karol Kaminski; Katarzyna Ptaszynska-Kopczynska
Journal:  Ther Adv Respir Dis       Date:  2022 Jan-Dec       Impact factor: 5.158

5.  Assessment of electrocardiographic markers of acute and long-term hemodynamic improvement in patients with pulmonary hypertension.

Authors:  Michał Piłka; Szymon Darocha; Marta Banaszkiewicz; Maria Wieteska-Miłek; Małgorzata Mańczak; Rafał Mańczak; Piotr Kędzierski; Michał Florczyk; Anna Dobosiewicz; Adam Torbicki; Marcin Kurzyna
Journal:  Ann Noninvasive Electrocardiol       Date:  2020-04-26       Impact factor: 1.468

6.  The prediction of right atrial pressure using electrocardiogram: a novel approach.

Authors:  Marzieh Mirtajaddini; Nasim Naderi; Maryam Chenaghlou; Sepideh Taghavi; Ahmad Amin
Journal:  ESC Heart Fail       Date:  2021-09-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.